Sunday, December 10, 2006

cancer stem cells 12/10/06

Piccirillo SG, Reynolds BA, Zanetti N, Lamorte G, Binda E, Broggi G, Brem H, Olivi A, Dimeco F, Vescovi AL.
Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells. [ABSTRACT]
Nature. 2006 Dec 7;444(7120):761-765.

Dirks PB.
Cancer: Stem cells and brain tumours. [ABSTRACT]
Nature. 2006 Dec 7;444(7120):687-688. No abstract available.

Alcaraz WA, Gold DA, Raponi E, Gent PM, Concepcion D, Hamilton BA.
Zfp423 controls proliferation and differentiation of neural precursors in cerebellar vermis formation. [ABSTRACT]
Proc Natl Acad Sci U S A. 2006 Dec 6; [Epub ahead of print]

Chaichana K, Zamora-Berridi G, Camara-Quintana J, Quinones-Hinojosa A.
Neurosphere assays: growth factors and hormone differences in tumor and nontumor studies. [ABSTRACT]
Stem Cells. 2006 Dec;24(12):2851-7. Epub 2006 Aug 31.

Menendez P, Bueno C, Wang L.
Human embryonic stem cells: a journey beyond cell replacement therapies. [ABSTRACT]
Cytotherapy. 2006;8(6):530-41.

Chebotaev D, Yemelyanov A, Zhu L, Lavker RM, Budunova I.
The tumor suppressor effect of the glucocorticoid receptor in skin is mediated via its effect on follicular epithelial stem cells. [ABSTRACT]
Oncogene. 2006 Dec 4; [Epub ahead of print]

Choudhury AR, Ju Z, Djojosubroto MW, Schienke A, Lechel A, Schaetzlein S, Jiang H, Stepczynska A, Wang C, Buer J, Lee HW, von Zglinicki T, Ganser A, Schirmacher P, Nakauchi H, Rudolph KL.
Cdkn1a deletion improves stem cell function and lifespan of mice with dysfunctional telomeres without accelerating cancer formation. [ABSTRACT]
Nat Genet. 2006 Dec 3; [Epub ahead of print]

Klein WM, Wu BP, Zhao S, Wu H, Klein-Szanto AJ, Tahan SR.
Increased expression of stem cell markers in malignant melanoma. [ABSTRACT]
Mod Pathol. 2006 Nov 24; [Epub ahead of print]

Rao MS, Reddy JK.
Pancreatic stem cells: differentiation options. [ABSTRACT]
Stem Cell Rev. 2005 Sep;1(3):265-72.

Shupe T, Petersen BE.
Evidence regarding a stem cell origin of hepatocellular carcinoma. [ABSTRACT]
Stem Cell Rev. 2005 Sep;1(3):261-4.

Alison MR.
Liver stem cells: implications for hepatocarcinogenesis. [ABSTRACT]
Stem Cell Rev. 2005 Sep;1(3):253-60.

Gostjeva EV, Thilly WG.
Stem cell stages and the origins of colon cancer: a multidisciplinary perspective. [ABSTRACT]
Stem Cell Rev. 2005 Sep;1(3):243-52.

Smith GH.
Stem cells and mammary cancer in mice. [ABSTRACT]
Stem Cell Rev. 2005 Sep;1(3):215-24.

Passegue E, Weisman IL.
Leukemic stem cells: where do they come from? [ABSTRACT]
Stem Cell Rev. 2005 Sep;1(3):181-8.

Liu G, Yuan X, Zeng Z, Tunici P, Ng H, Abdulkadir IR, Lu L, Irvin D, Black KL, Yu JS.
Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma. [ABSTRACT]
Mol Cancer. 2006 Dec 2;5(1):67 [Epub ahead of print]

Labels: ,

Read more!

pancreatic cancer weekly 12/10/06

Lee EJ, Gusev Y, Jiang J, Nuovo GJ, Lerner MR, Frankel WL, Morgan DL, Postier RG, Brackett J, Schmittgen TD. [ABSTRACT]
Expression profiling identifies microRNA signature in pancreatic cancer. Int J Cancer. 2006 Dec 5; [Epub ahead of print]

Dragovich T, Huberman M, Von Hoff DD, Rowinsky EK, Nadler P, Wood D, Hamilton M, Hage G, Wolf J, Patnaik A. [ABSTRACT]
Erlotinib plus gemcitabine in patients with unresectable pancreatic cancer and other solid tumors: phase IB trial.
Cancer Chemother Pharmacol. 2006 Dec 6; [Epub ahead of print]

Mudali SV, Fu B, Lakkur SS, Luo M, Embuscado EE, Iacobuzio-Donahue CA.[ABSTRACT]
Patterns of EphA2 protein expression in primary and metastatic pancreatic carcinoma and correlation with genetic status.
Clin Exp Metastasis. 2006 Dec 5; [Epub ahead of print]

Bianco C, Giovannetti E, Ciardiello F, Mey V, Nannizzi S, Tortora G, Troiani T, Pasqualetti F, Eckhardt G, de Liguoro M, Ricciardi S, Del Tacca M, Raben D, Cionini L, Danesi R.[ABSTRACT]
Synergistic Antitumor Activity of ZD6474, An Inhibitor of Vascular Endothelial Growth Factor Receptor and Epidermal Growth Factor Receptor Signaling, with Gemcitabine and Ionizing Radiation against Pancreatic Cancer.
Clin Cancer Res. 2006 Dec 1;12(23):7099-107.

Rao MS, Reddy JK. [ABSTRACT]
Pancreatic stem cells: differentiation options.
Stem Cell Rev. 2005 Sep;1(3):265-72.

Chu CS, Xue B, Tu C, Feng ZH, Shi YH, Miao Y, Wen CJ.[ABSTRACT]
NRAGE suppresses metastasis of melanoma and pancreatic cancer in vitro and in vivo.
Cancer Lett. 2006 Nov 29; [Epub ahead of print]

Read more!